[1] Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M.MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch. 2004; 444(3): 224-30.
[2] Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol. 2008; 23(12): 1541-52.
[3] Jia Y, Persson C, Hou L, Zheng Z, Yeager M, Lissowska J, et al. A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control. 2010; 21(2): 313-21.
[4] Nakayama J. Dual Roles of Gastric Gland Mucin-specific O-glycans in Prevention of Gastric Cancer. Acta Histochem Cytochem. 2014; 47(1): 1-9.
[5] Babu SD1, Jayanthi V, Devaraj N, Reis CA, Devaraj H. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 2006; 19; 5: 10.
[6] Park KK1, Yang SI1, Seo KW1, Yoon KY1, Lee SH, et al. Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection. Gastroenterol Res Pract. 2015. doi: 10.1155/2015/946359.
[7] Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999; 59(5): 1003-7.
[8] Reis CA, David L, Carvalho F, Mandel U, de Bolós C, Mirgorodskaya E, et al. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem. 2000; 48(3): 377-88.
[9] Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995; 55(12): 2681-90.
[10] Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, et al. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res ClinOncol. 2006;132(12): 817-23.
[11] Kwon JA, Lee SY, Ahn EK, Seol SY, Kim MC, Kim SJ, et al. Short rare MUC6 minisatellites-5 alleles influence susceptibility to gastric carcinoma by regulating gene. Hum Mutat. 2010; 31(8): 942-9.
[12] Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. Int J Clin Exp Pathol. 2013; 6(4): 613-21.
[13] Shiratsu K, Higuchi K, Nakayama J. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach. Cancer Sci. 2014; 105(1): 126-33.
[14] Pigny P, Guyonnet-Duperat V, Hill AS, Pratt WS, Galiegue-Zouitina S, d'Hooge MC, et al. Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics. 1996; 38(3): 340-52.
[15] Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene. 2007; 26(45): 6566-76.
[16] Gratchev A, Bohm C, Riede E, Foss HD, Hummel M, Mann B, et al. Regulation of mucin MUC2 gene expression during colon carcinogenesis. Ann NY Acad Sci. 1998; 859: 180-183.
[17] Siedow A, Szyf M, Gratchev A, Kobalz U, HanskiML, Bumke-Vogt C, et al. De novo expression of the Muc2gene in pancreas carcinoma cells is triggered by promoter demethylation. Tumour Biol. 2002; 23(1): 54-60.
[18] Mesquita P, Peixoto AJ, Seruca R, Hanski C, Almeida R, SilvaF, et al. Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. Cancer Lett. 2003; 89: 129-136.
[19] Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS, et al. The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol. 1998; 186(4): 398-405.
[20] Garcia E, Carvalho F, Amorim A, David L. MUC6 gene polymorphism in healthy individuals and in gastric cancer patients from northern Portugal. Cancer Epidemiol Biomarkers Prev. 1997; 6(12): 1071-4.
[21] Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res. 1999; 59(16): 4083-9.
[22] Perrais M, Pigny P, Buisine MP, Porchet N, Aubert JP, Van Seuningen-Lempire I. Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter. J Biol Chem. 2001; 276(18): 15386-96.
[23] Shiratsu K, Higuchi K, Nakayama J. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach. Cancer Sci. 2014; 105(1): 126-33.
[24] Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007; 128(4): 683-92.
[25] Toyota M1, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol. 2005; 32(5): 521-30.
[26] Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005; 5(3): 223-31.
[27] Bird AP1, Wolffe AP. Methylation-induced repression--belts, braces, and chromatin. Cell. 1999; 99(5): 451-4.
[28] Jones PA1, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999; 21(2): 163-7.